BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 6, 2002
View Archived Issues
Pliva and GSK extend macrolide antibiotics collaboration agreement
Read More
Eplerenone for the long-term treatment of chronic heart failure
Read More
UCB-34714: a new levetiracetam analogue discovered at UCB
Read More
Galapagos Genomics broadens functional genomics collaboration with P&G
Read More
CIMA advances OraVescent fentanyl into clinical trials
Read More
Hexvix demonstrates benefit in detection of bladder cancer
Read More
Lexicon Genetics initiates small molecule discovery in obesity
Read More
Phase I/II results for HuMax-IL-15 in RA
Read More
Paratek receives SBIR grant for antimalarial tetracyclines
Read More
Solvay identifies potent, selective, orally active CB1 antagonist, initially targeted for psychosis
Read More
Novel 5-HT2A/2C and H1 antagonist from Janssen with anxiolytic-like activity
Read More
Clinical development candidate for anxiety selected at Janssen
Read More
Inhibitors of phosphopantetheine adenylyltransferase as potential antibacterial agents
Read More
New class of PTP1B inhibitors discovered at Morphochem
Read More
SDZ-LAV-694: a topical antiproliferative agent with a favorable pharmacological profile
Read More
Phase II clinical results in psoriasis announced for IDEC-114
Read More
SGN-30 safe and associated with antitumor activity in phase I trial
Read More
ACAM-1000 smallpox vaccine completes phase I trial
Read More
CX-516 enters testing for fragile X syndrome
Read More
Actimmune shows survival benefit in phase III IPF trial
Read More
Eloxatin now available for second-line treatment of colorectal cancer
Read More
Enrollment completed in phase II study of EGF cancer vaccine
Read More
Prodrugs of excitatory amino acids prepared at Lilly
Read More
New agents for diabetes and hyperlipidemia designed by Takeda scientists
Read More
Orally bioavailable and safe SGLT2 inhibitors useful for diabetes and related disorders
Read More
Tachykinin antagonists and potential uses described in recent patent
Read More
Compounds that upregulate LDL receptor expression disclosed in patent literature
Read More